What is the normal range for a random (non‑fasting) plasma glucose level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Random Normal Glucose Range

A random (non-fasting) plasma glucose level below 200 mg/dL (11.1 mmol/L) is considered normal in asymptomatic individuals, while values of 140-180 mg/dL (7.8-10.0 mmol/L) warrant definitive testing due to high specificity for dysglycemia. 1

Diagnostic Thresholds for Random Glucose

Random glucose is defined as a measurement taken at any time of day without regard to the interval since the last meal. 1

Diabetes Diagnosis

  • A random plasma glucose ≥200 mg/dL (11.1 mmol/L) meets the diagnostic threshold for diabetes when accompanied by classic symptoms (polyuria, polydipsia, unexplained weight loss, blurred vision, fatigue) or hyperglycemic crisis. 1
  • In the absence of unequivocal hyperglycemia or symptoms, this finding must be confirmed on a subsequent day by repeat testing using any diagnostic method (fasting glucose, 2-hour OGTT, or A1C). 1

Intermediate Values Requiring Further Testing

  • Random glucose values between 140-180 mg/dL (7.8-10.0 mmol/L) have 92-98% specificity for diabetes, making them highly suggestive of dysglycemia despite lower sensitivity (39-55%). 1
  • Patients with random glucose in this range should undergo definitive testing with fasting plasma glucose, 2-hour OGTT, or A1C measurement. 1

Normal Range

  • Random glucose values below 140 mg/dL (7.8 mmol/L) in asymptomatic individuals generally indicate normal glucose metabolism, though this does not exclude prediabetes or early diabetes. 1
  • The upper limit of truly "normal" fasting glucose is 109 mg/dL (6.1 mmol/L), providing context for interpreting random values. 1

Clinical Performance Characteristics

Random glucose testing has important limitations compared to fasting measurements:

  • Sensitivity ranges from only 39-55% at thresholds of 140-180 mg/dL, meaning many cases of diabetes will be missed. 1
  • Specificity is excellent at 92-98%, so elevated values are highly reliable when present. 1
  • Random glucose has moderate discrimination (AUC 0.66-0.68) for identifying dysglycemia in children and adolescents, performing better than A1C or fructosamine in some populations. 2

Important Caveats

Random glucose should not be used as a primary screening test in asymptomatic individuals because of its poor sensitivity and the lack of standardization regarding timing of meals. 1

When random glucose is used diagnostically:

  • Confirmation is mandatory unless the patient presents with hyperglycemic crisis or classic symptoms plus glucose ≥200 mg/dL. 1
  • The confirmatory test can be the same test repeated or a different test (e.g., fasting glucose or A1C), and both tests can be performed from the same blood draw or on different days. 1

Pre-analytic factors significantly affect glucose measurements:

  • Plasma samples must be centrifuged and separated immediately after collection to prevent falsely low values from ongoing glycolysis. 3
  • Random glucose shows greater day-to-day variability than A1C, making it less reliable for borderline results. 1

Prediabetes Context

For reference, prediabetes is defined by:

  • Fasting glucose 100-125 mg/dL (5.6-6.9 mmol/L), or 1
  • 2-hour OGTT glucose 140-199 mg/dL (7.8-11.0 mmol/L), or 1
  • A1C 5.7-6.4% (39-47 mmol/mol). 1

Random glucose values do not have established prediabetes cut-points, which is another reason fasting or post-load testing is preferred for screening. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Practical Considerations for Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What should a 61-year-old woman with diabetes do when she develops severe hyperglycemia after starting prednisone 10 mg twice daily for sciatica?
What are the 2026 American Diabetes Association (ADA) clinical practice recommendations for screening, diagnosis, glycemic targets, lifestyle modification, pharmacologic therapy, cardiovascular and renal risk reduction, and monitoring in adults with diabetes?
Is a fasting plasma glucose of 128 mg/dL and an HbA1c of 5.8 % diagnostic of diabetes or prediabetes?
In a 46-year-old male with BMI 44 kg/m², type 2 diabetes, hypertension, hyperlipidemia, microalbuminuria (urine albumin excretion 680 mg/24 h), and an HbA1c of 13.5 % who is taking glipizide 10 mg twice daily and metformin extended‑release 1000 mg twice daily, what additional medication(s) should be added?
What is the appropriate next management for an 81‑year‑old woman with type 2 diabetes, hemoglobin A1c 6.9%, impaired renal function (elevated BUN, reduced eGFR) and significant albuminuria/proteinuria who is currently taking atenolol, aspirin, atorvastatin, gabapentin, insulin, semaglutide, and valsartan (Diovan)?
What are alternative options to melatonin, trazodone, temazepam (Restoril), and zolpidem (Ambien) for treating insomnia?
Are cefuroxime and ceftriaxone the same drug?
What is the relationship between obesity and asthma?
How should I manage a 16‑month‑old child with wheezing but no respiratory distress?
What is the recommended dosage of ferrous gluconate?
What is the first-line medication for insomnia in an elderly patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.